ReproNovo
Lausanne-based HealthTech startup ReproNovo, a company innovating treatments for reproductive medicine and women’s health
ReproNovo has raised €57M across 1 funding round from 5 investors, most recently a Series A round in May 2025. Based in Lausanne, Switzerland; active in Healthtech. Data as of 28 Oct 2026.
Lausanne, Switzerlandrepronovo.com ↗
Total raised
€57M
€57,000,000
Funding rounds
1
Investors
5
distinct backers
Active since
2025-05
latest 2025-05
Funding by year
EUR raised per yearReproNovo — funding by year — interactive chart.
Data table
| ReproNovo — funding by year | |
|---|---|
| 2025 | €57M |
Signals
High confidenceRaise-next likelihood63
base rate 44% for Series A
- ▲ In typical raise window
- ▼ Low backer re-investment
Timing: in window vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2025-05-21 | Series A | €57M | ALSA Ventures,AXA IM Alts,Jeito Capital,M Ventures,Ysios Capital | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData